Denali Therapeutics IncEquity-NMS: DNLI
Equity-NMS: DNLI
$16.54
-0.48
(20 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$16.54
Open
$16.54
Today’s high
$17.00
Today’s low
$16.21
52W low
$15.45
52W high
$33.31
1Y
-45.53%
5Y
-4.71%
PE
-19.01
EPS (TTM)
-0.91
Shares O/S
138.99M
Market cap
2.3B
Insights
DNLI price is above its 200 day moving average
DNLI PE is in the low end of its range over the past 2 years
DNLI is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Denali Therapeutics Inc

Denali Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company’s clinical-stage programs include Antibody Transport Vehicle (ATV): triggering receptors expressed on myeloid cells 2 (TREM2), Protein Transport Vehicle (PTV): progranulin (PGRN), eukaryotic initiation factor 2 B (eIF2B), receptor-interacting serine/threonine protein kinase 1 (RIPK1), Enzyme Transport Vehicle (ETV): iduronate 2-sulfatase (IDS) and leucine-rich repeat kinase 2 (LRRK2), which are in various Phases ranging from Phase I through Phase III.

The Company’s product candidates include DNL310, TAK-594/DNL593, TAK-920/DNL919, BIIB122/DNL151, DNL343, SAR443820/DNL788 and SAR443122/DNL758. The Company engineers its product candidates to cross the BBB, and act directly in the brain. .


FAQs

Can I buy Denali Therapeutics Inc shares in India?
How to buy Denali Therapeutics Inc shares in India?
What is the share price of Denali Therapeutics Inc?
What is the Market Capitalization of Denali Therapeutics Inc?
What is the PE ratio of Denali Therapeutics Inc?
Is Denali Therapeutics Inc a good stock to buy?
In which sector / industry does Denali Therapeutics Inc operate?